| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
SkinHealth Systems Inc.
$0.7
+0.02 (+2.22%)
Market Cap
91.18 M
EPS
-0.22
P/E Ratio
-
Value Trade
309.39 K
3.78 %
Week
9.45 %
1 Month
10.54 %
3 Month
-38.01 %
6 Month
-95 %
5 Year
-93.66 %
All Time
Cash Data
Cash Position
-
Monthly Burn
-
Runway
-
Overview
Volume
262.34 K
52 Week Range
0.55 - 2.69
% held by Insiders
38.76 %
% held by Institutions
51.54 %
Enterprise Value
231.28 M
Total Shares
130.12 M
Short %
8.87 %
Float Shares
83.93 M
Company Description
locked
Upcoming Catalyst
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in SKIN
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
SKIN Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-11-20 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-11-20 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-11-20 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
SKIN▲ +2.2%today
Hydrafacial Expands Treatment Personalization and Elevates Results with Two New Treatment Enhancers
SkinHealth Systems has launched two new Treatment Enhancers for Hydrafacial: HydraGlow Pre-Extraction Peel and Hydralock HA Biocellulose Mask. These products are designed to enhance treatment personalization and effectiveness, improving skin exfoliation and hydration. Providers can integrate these enhancers into existing protocols, offering clients a more tailored skincare experience.
Read more →SKIN▼ -5.3%on this news
Hydrafacial Introduces HydraScalp® with Keravive™ as Next Evolution in Scalp Health
SkinHealth Systems Inc. has launched HydraScalp with Keravive, a non-invasive scalp treatment designed to improve scalp health and hair appearance. Utilizing Hydrafacial's Vortex-Fusion Technology, the treatment aims to cleanse and nourish the scalp effectively. Clinical studies indicate that users experience notable improvements in hair fullness and scalp hydration after treatment.
Read more →SKINSkinHealth Systems Reports First Quarter 2026 Financial Results Long Beach, Calif.
SkinHealth Systems Inc. reported its financial results for the first quarter of 2026, showing a decrease in net sales to $64.9 million, down 6.7% year-over-year. Despite this decline, the company achieved a strong performance in adjusted EBITDA, reaching $8.5 million. The CEO noted the commitment to improve execution and invest in growth capabilities, although the company revised its full-year revenue outlook downwards amid challenging market conditions. Operating expenses decreased significantly, contributing to a narrower net loss of $6.6 million.
Read more →SKINDocument The Beauty Health Company Announces Corporate Rebrand to SkinHealth Systems, Reflecting Evolution into a Clinically Driven, Science-Backed Medical Aesthetics Platform The Company will continue trading on the Nas
The Beauty Health Company has rebranded itself as SkinHealth Systems Inc., reflecting its evolution into a clinically driven medical aesthetics platform. The name change, effective immediately, maintains the Nasdaq ticker symbol 'SKIN'. This transition highlights the company's commitment to scientific validation and improving device utilization in the aesthetics market. The firm emphasizes building a comprehensive suite of skin health technologies and solutions while continuing to leverage its flagship product, Hydrafacial. However, there are several risks associated with this strategic shift that may impact its performance.
Read more →SKIN▼ -5.8%on this news
BeautyHealth Reports Full Year and Fourth Quarter 2025 Financial Results Long Beach, Calif.
BeautyHealth reported its financial results for the full year and fourth quarter of 2025, showing a net loss of $8.1 million for Q4 and a total net sales of $300.8 million for the year. While the company faced a decline in sales and placed fewer delivery systems than in 2024, it achieved improved gross margins and reduced its operational expenses. Looking ahead, BeautyHealth aims for modest revenue stability in 2026 while investing in innovative solutions, despite potential market challenges.
Read more →SKINBeautyHealth Expands Skin Health Ecosystem with Growing Adoption of SkinStylus Nano-Channeling, a Popular Pairing with Hydrafacial Treatments
The Beauty Health Company (NASDAQ: SKIN) is expanding its skin health ecosystem with the increasing popularity of its Hydrafacial treatments combined with SkinStylus Nano-Channeling. This combination is gaining traction among aesthetic providers, enhancing treatment performance and client satisfaction. The non-invasive nature of nano-channeling helps improve skin quality without downtime, making it an attractive option for consumers.
Read more →SKINBeautyHealth to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026
BeautyHealth Company, known for its Hydrafacial brand, will report its fourth quarter and full year 2025 financial results on March 12, 2026. An investor conference call is scheduled for the same day at 4:30 p.m. ET. The company emphasizes its commitment to transparency through various disclosure methods.
Read more →SKINBeautyHealth Releases Third Annual Skintuition Report
The Beauty Health Company released its third annual Skintuition Report, revealing a shift towards prioritizing skin health over traditional volume-enhancing procedures. The report indicates that 75% of consumers are now focusing on treatments that improve skin quality. Hydrafacial has introduced a new booster aimed at enhancing skin regeneration, aligning with consumer demand for long-term skin health solutions.
Read more →SKIN▼ -12.2%on this news
BeautyHealth Reports Third Quarter 2025 Financial Results Long Beach, Calif.
BeautyHealth (NASDAQ: SKIN) reported third quarter financial results for 2025, indicating a net sales decrease of 10.3%, totaling $70.7 million. Despite this decline, adjusted EBITDA improved to $8.9 million, reflecting ongoing operational efficiencies. The gross margin also saw significant improvement, rising to 64.6%, attributed to a favorable shift toward consumable sales. However, device sales remain under pressure, highlighting challenges in the market.
Read more →SKINDocument BeautyHealth Appoints Philippe Schaison, PharmaD, to Board of Directors Global Aesthetics Leader Brings Deep Industry Expertise and Proven Track Record Driving Growth Across Health, Beauty, and Consumer Sectors
The BeautyHealth Company (NASDAQ SKIN) appointed Philippe Schaison, PharmaD, to its Board of Directors, effective October 30, 2025. Schaison brings over 20 years of experience in the aesthetics, biotech, and consumer health sectors, and has held leadership positions at notable companies such as Allergan and Johnson & Johnson. This appointment is expected to enhance the company's growth strategy, particularly for its flagship brand, Hydrafacial. Additionally, Schaison will contribute to the Board's Compensation and Nominating Corporate Governance Committees.
Read more →SKINDocument The Beauty Health Company Names Pedro Malha President and Chief Executive Officer Global Healthcare and Medical Device Executive with More Than 20 Years of Experience Assumes Role Effective October 1 Marla Beck
The Beauty Health Company has appointed Pedro Malha as the new President and CEO, effective October 1, 2025. He takes over from Marla Beck, who steps down after successfully guiding the company through significant transformation. Malha joins with over 20 years of experience in the healthcare and medical device industries. The company is positioned for continued growth with a strong innovation pipeline as it moves forward.
Read more →SKINBeautyHealth Reports Second Quarter 2025 Financial Results Raises guidance on strong execution and disciplined cost management Advances science-backed innovation with successful launch of the HydraFillic with Pep9 Booste
BeautyHealth (NASDAQ: SKIN) reported its financial results for the second quarter of 2025, highlighting strong performance driven by demand for consumables and innovation in product offerings. The company raised its full-year guidance based on a solid operational foundation and improved margins, despite a decline in total net sales due to a reduced number of delivery systems sold. CEO Marla Beck emphasized the company's ability to generate recurring revenue and manage costs effectively. The macroeconomic challenges have prompted strategic refinements, including a transition to a distributor in the China market.
Read more →SKIN▼ -7.7%on this news
The BeautyHealth Company Announces Convertible Debt Refinancing Refinancing extends maturity of existing debt and strengthens Company's financial position to advance growth strategy LONG BEACH, Calif.--(GLOBE NEWSWIRE)
The BeautyHealth Company (NASDAQ:SKIN) has announced a refinancing of its existing convertible debt through privately negotiated exchange agreements. The company will exchange about $413.2 million of its 1.25% convertible senior notes due in 2026 for $250.0 million in new convertible senior secured notes due in 2028, along with cash. The refinancing aims to enhance its financial stability and provide the necessary flexibility for long-term growth initiatives. CEO Marla Beck highlighted the importance of this move in fostering greater investment in innovation and commercial operations.
Read more →SKIN▼ -12.7%on this news· ran to +32% by day 1
BeautyHealth Reports First Quarter 2025 Financial Results Long Beach, Calif.
BeautyHealth reported its first quarter 2025 financial results, revealing net sales of $69.6 million, a 14.5% decrease from the same quarter last year. Despite the decline in overall revenue, the company noted strong performance in consumables, leading to improved gross profit and margins. The company made strategic decisions, including relocating production to the U.S. to mitigate risks and transitioning its China operations to a distributor model. CEO Marla Beck emphasized the company's strong execution and potential for sustainable growth, despite prevailing macroeconomic challenges.
Read more →SKINBeautyHealth Reports Full Year and Fourth Quarter 2024 Financial Results Delivers fourth quarter and full year net sales of $83.5 million and $334.3 million Long Beach, Calif.
BeautyHealth reported its financial results for Q4 2024, with net sales of $83.5 million and a full year total of $334.3 million. The company exceeded its guidance for adjusted EBITDA, recording $9 million for the quarter. Despite an increase in consumable sales and gross margins, the overall revenue declined compared to the previous year due to fewer delivery systems sold. Looking ahead, BeautyHealth aims to navigate industry headwinds while maintaining its position as a leading brand with plans for further innovations and partnerships.
Read more →SKINDocument The Beauty Health Company Strengthens Commercial Leadership Team with Chief Revenue Officer and Chief Marketing Officer Appointments
The Beauty Health Company announced the appointment of Ron Menezes as Chief Revenue Officer and Carrie Caulkins as Chief Marketing Officer, effective October 15, 2024. Menezes, former President and CEO of Sientra, brings over 20 years of experience in product commercialization and revenue generation. Caulkins joins from Galderma, where she led global business strategies for the aesthetics sector. These leadership changes aim to drive sales growth and enhance profitability for Beauty Health, particularly focusing on the flagship brand, Hydrafacial.
Read more →SKINDocument BeautyHealth Appoints Stephen J. Fanning to Board of Directors Medical Aesthetics Veteran Brings Extensive Industry Knowledge and Proven Success in Driving Global Growth LONG BEACH, Calif.--(BUSINESS WIRE)
BeautyHealth has appointed Stephen J. Fanning to its Board of Directors, effective December 12, 2024. Fanning, a veteran in medical aesthetics, previously served as the Chairman of Hydrafacial and has extensive experience in driving growth within the industry. His leadership roles at various companies, including Spectrum Solutions and Z-Medica, highlight his ability to enhance business performance. This strategic appointment is expected to aid BeautyHealth in achieving consistent growth and profitability.
Read more →SKINBeautyHealth Reports Third Quarter 2024 Financial Results Delivers third quarter net sales of $78.8 million Delivers improved profitability as strategic initiatives start to take hold Successfully launches Hydralock HA B
BeautyHealth (NASDAQ: SKIN) reported its third-quarter financial results for 2024, highlighting net sales of $78.8 million, which is a 19.1% decrease year-over-year. The company showcased improved profitability through operational initiatives and the successful launch of the Hydralock HA Booster. Despite these enhancements, BeautyHealth revised its full-year sales guidance downwards due to continued pressure on delivery systems. However, the company remains optimistic about future growth, emphasizing strategic changes in its manufacturing and leadership structures.
Read more →SKINBeautyHealth Reports Second Quarter 2024 Financial Results Delivers second quarter net sales of $90.6 million Year-over-year operating expense improvement of nearly $18 million or 22% Revises full year financial guidance
BeautyHealth Company (NASDAQ: SKIN) reported its second quarter financial results, with net sales of $90.6 million, a decrease of 22.9% from the same period last year. The decline in sales was attributed to lower equipment sales, although consumables sales showed growth. The company revised its full-year financial guidance downward, anticipating continued pressure on delivery systems sales but remains optimistic about Hydrafacial’s market potential. Despite operational improvements, the gross margin and adjusted EBITDA have been negatively impacted due to inventory-related issues.
Read more →SKINBeautyHealth Reports First Quarter 2024 Financial Results Delivers first quarter net sales of $81.4 million year-over-year operating expense improvement of $6.1 million Repurchases $192.3 million of convertible notes thr
BeautyHealth (NASDAQ: SKIN) reported its first quarter 2024 financial results, revealing net sales of $81.4 million, a 5.7% decrease year-over-year. Despite this decline, the company achieved a significant improvement in net loss, reducing it to $(0.7) million from $(20.3) million in the previous year. The report highlighted an increase in sales of consumables, which partially offset the drop in equipment sales. Looking forward, BeautyHealth projects sales growth and positive adjusted EBITDA for the upcoming quarters as it continues to execute its strategic priorities.
Read more →SKINDocument BeautyHealth Announces Appointment Of Marla Beck As Chief Executive Officer
The Beauty Health Company (NASDAQ SKIN) has appointed Marla Beck as the permanent President and Chief Executive Officer, following her role as Interim CEO since November 2023. The Board of Directors expressed unanimous support for Beck, citing her proven leadership and extensive industry experience. Under her guidance, the company aims to enhance operational excellence and drive growth, particularly focusing on its flagship brand, Hydrafacial. Beck's strategic vision is expected to positively impact the company's future and strengthen its position in the beauty and aesthetics market.
Read more →SKINBeautyHealth Reports Full Year and Fourth Quarter 2023 Financial Results Delivers net sales of $398 million for the full year and $96.8 million for the fourth quarter driven by growth across international markets Long Be
BeautyHealth reported its financial results for the full year and fourth quarter of 2023, revealing net sales of $398 million for the year, a rise of 8.8% from 2022. However, fourth quarter sales fell by 1.3% year-over-year to $96.8 million due to lower equipment sales in the Americas, though growth was observed in consumables. The company announced a net loss of $9.4 million for the fourth quarter, contrasting sharply with a profit in the same period the previous year. Despite these challenges, there was noted strength in international markets, especially Asia-Pacific.
Read more →SKIN▲ +8.3%on this news· ran to -61% by day 1
BeautyHealth Reports Third Quarter 2023 Financial Results Revises financial guidance on lower-than-expected U.S. revenue and incurs restructuring charges for device upgrades Delivers net sales of $97.4 million driven by
BeautyHealth Company (NASDAQ: SKIN) reported a third quarter net sales of $97.4 million, marking a 10% increase year-over-year, largely fueled by growth in the Asia-Pacific and EMEA regions. However, the company revised its fiscal year 2023 net sales guidance downward due to lower-than-expected revenue from U.S. markets and incurred $63.1 million in restructuring costs related to device upgrades. The gross margin significantly decreased to (12.9)% from 69.1% a year ago, leading to a substantial net loss of $(73.8) million. Management expressed confidence in its strategy to restore brand trust and improve performance with new pricing and device offerings.
Read more →SKIN▲ +23.6%on this news
pressrelease12sep2 BeautyHealth Announces Business Transformation Program to Drive Profitability and Growth; Board of Directors Authorizes $100 Million Share Repurchase
The Beauty Health Company (NASDAQ: SKIN) has announced a business transformation program aimed at improving profitability and operational efficiency. The initiative is expected to yield over $20 million in annualized cost savings during the first quarter of 2024 and an additional $15 million savings in the second quarter. Alongside this program, the company's Board of Directors has given the go-ahead for a $100 million share repurchase plan, highlighting their commitment to creating shareholder value. Updates on the transformation program are anticipated during the upcoming third quarter earnings call in November 2023.
Read more →SKIN▼ -5.4%on this news
Document BeautyHealth Names Michael Monahan Chief Financial Officer
BeautyHealth has appointed Michael Monahan as its new Chief Financial Officer, effective August 10, 2023, following the departure of Liyuan Woo. Monahan, who has nearly 15 years of experience as a CFO, is expected to enhance the company's financial strategies amidst its vision of a multi-brand ecosystem. CEO Andrew Stanleick expressed confidence in Monahan's capabilities, highlighting the company's opportunities for profitable growth and innovation. Woo will remain with the company as an advisor until September 1, 2023, to ensure a smooth transition.
Read more →SKIN▼ -5.4%on this news
BeautyHealth Reports Second Quarter 2023 Financial Results Delivers double-digit net sales growth on demand for Hydrafacial Confirms 2023 net sales and 2025 financial guidance, refines 2023 adjusted EBITDA margin guidanc
BeautyHealth reported a net sales growth of 13% year-over-year for Q2 2023, reaching $117.5 million, largely attributed to increased demand for Hydrafacial. The company reaffirmed its net sales guidance for 2023 and its long-term target for 2025, while adjusting its EBITDA margin guidance. However, it faced a decrease in gross margin due to a shift towards lower-margin refurbished devices, which impacted profitability. Positive trends were noted across APAC, particularly in China, showcasing robust market recovery.
Read more →SKIN▼ -6.7%on this news
BeautyHealth Reports First Quarter 2023 Financial Results On strong consumer demand, delivers double-digit net sales growth in line with 2023 plan Raises fiscal 2023 net sales guidance Long Beach, Calif.
The Beauty Health Company reported a 14% year-over-year increase in net sales for Q1 2023, reaching $86.3 million. The growth reflects strong consumer demand for their flagship Hydrafacial treatments, particularly in the Americas. The company has raised its fiscal year 2023 net sales guidance to $460-480 million amid optimistic outlooks for both the Syndeo launch and re-acceleration in the Chinese market. However, the company reported a net loss of $22.3 million and a decline in gross margin.
Read more →SKINMaturing into a Multi-Brand Ecosystem, BeautyHealth Appoints Aesthetics Veteran Brad Hauser as Chief Operating Officer Newly created role establishes end-to-end product oversight, from innovation to go-to-market
The Beauty Health Company (NASDAQ: SKIN) has appointed Brad Hauser as Chief Operating Officer, a newly created role that encompasses full oversight of the product lifecycle from innovation to market introduction. Hauser, an experienced veteran in the aesthetics field, will enhance operational leadership while continuing to manage product development and R&D. This organizational change aims to support the international launch of Syndeo and strengthen the company's multi-brand ecosystem strategy.
Read more →SKIN▲ +11.4%on this news
BeautyHealth to Acquire SkinStylus , FDA-Cleared Microneedling Device Acquisition is a strategic step in portfolio build-up and BeautyHealth long-term vision Long Beach, Calif.
BeautyHealth announced its acquisition of SkinStylus, an FDA-cleared microneedling device, as part of its strategy to expand its portfolio. This acquisition is significant as BeautyHealth aims to become a leading beauty, health, and wellness platform. The microneedling market is expected to grow significantly, reaching $1 billion by 2030. The integration of SkinStylus into BeautyHealth's offerings is expected to enhance the user experience and drive revenue growth starting in 2024.
Read more →SKIN▲ +11.4%on this news
BeautyHealth Reports Full Year and Fourth Quarter 2022 Financial Results Delivers +41% year-over-year topline growth for the year and exceeds market expectations for eighth consecutive quarter Increases adjusted EBITDA +
BeautyHealth (NASDAQ: SKIN) reported a strong financial performance for the full year and fourth quarter of 2022, highlighting a 41% increase in net sales year-over-year. The company achieved an adjusted EBITDA growth of 46%, reflecting ongoing demand and effective strategies. Despite facing challenges like declining gross margins and the impact of China's zero-Covid policy, BeautyHealth maintains positive growth expectations for 2023 and beyond, with a focus on expanding its innovative product launches.
Read more →SKIN▲ +13%on this news· ran to +24% by day 3
BeautyHealth Enters into $100 Million Accelerated Share Repurchase Agreement Long Beach, Calif.
BeautyHealth Enters into $100 Million Accelerated Share Repurchase Agreement Long Beach, Calif., November 10, 2022 - The Beauty Health Company (NASDAQ SKIN), home to flagship brand Hydrafacial, today announced that it has entered into an accelerated share repurchase agreement ("
Read more →SKIN▼ -5.3%on this news· ran to -25% by day 1shared move
BeautyHealth Reports Third Quarter 2022 Financial Results Net sales beat expectations for seventh consecutive quarter Company raises 2022 net sales guidance on continued momentum and strong demand, revises adjusted EBITD
BeautyHealth Reports Third Quarter 2022 Financial Results Net sales beat expectations for seventh consecutive quarter Company raises 2022 net sales guidance on continued momentum and strong demand, revises adjusted EBITDA guidance against a complex macro backdrop Long Beach,
Read more →SKIN▲ +11.3%on this news· ran to +23% by day 1
BeautyHealth Announces $200 million Share Repurchase Authorization Enters into $100 million accelerated share repurchase agreement Long Beach, Calif.
BeautyHealth Announces $200 million Share Repurchase Authorization Enters into $100 million accelerated share repurchase agreement Long Beach, Calif., Sep. 27, 2022 - The Beauty Health Company (NASDAQ SKIN), home to flagship brand Hydrafacial, today announced its Board of Direc
Read more →SKIN▲ +7.2%on this news
A Harbinger of Beauty Industry Resiliency, BeautyHealth Announces Three-Year Plan to Double Sales, At Least Triple Profit Company hosts Analyst and Investor Day in New York City today Expects growth across all channels a
A Harbinger of Beauty Industry Resiliency, BeautyHealth Announces Three-Year Plan to Double Sales, At Least Triple Profit Company hosts Analyst and Investor Day in New York City today Expects growth across all channels and geographies, projecting EMEA and APAC businesses to ov
Read more →SKIN▼ -16.2%on this news
BeautyHealth Reports Record Second Quarter 2022 Financial Results All-time high quarterly net sales of $103.5 million, up +55.7% YoY Company raises net sales guidance and reaffirms adjusted EBITDA outlook for the year Ex
BeautyHealth Reports Record Second Quarter 2022 Financial Results All-time high quarterly net sales of $103.5 million, up +55.7% YoY Company raises net sales guidance and reaffirms adjusted EBITDA outlook for the year Exceptional results driven by acceleration of HydraFacial d
Read more →SKINBEAUTYHEALTH
BEAUTYHEALTH APPOINTS BLUEMERCURY FOUNDER MARLA BECK TO BOARD OF DIRECTORS LONG BEACH, Calif., June 6, 2022-The Beauty Health Company (NASDAQ SKIN), the breakthrough category creator at the intersection of traditional beauty and aesthetics with its flagship HydraFacial brand, to
Read more →SKIN▲ +11.6%on this news
The Beauty Health Company Reports Strong First Quarter 2022 Financial Results Increases 2022 Financial Guidance Long Beach, Calif.
The Beauty Health Company Reports Strong First Quarter 2022 Financial Results Increases 2022 Financial Guidance Long Beach, Calif., May 10, 2022 - The Beauty Health Company ( BeautyHealth or the Company NASDAQ SKIN), the breakthrough category creator at the intersection of trad
Read more →SKIN▼ -6%on this news
The Beauty Health Company Introduces New Digitally Connected HydraFacial Syndeo Delivery System Launch Represents a Significant Technology Upgrade from Existing HydraFacial Delivery System, with Data Collection Capabilit
The Beauty Health Company Introduces New Digitally Connected HydraFacial Syndeo Delivery System Launch Represents a Significant Technology Upgrade from Existing HydraFacial Delivery System, with Data Collection Capabilities for a Personalized and Connected Experience Long Beach
Read more →SKINThe Beauty Health Company Reports Record Fourth Quarter and Fiscal Year 2021 Financial Results Provides Fiscal Year 2022 Outlook Long Beach, Calif.
The Beauty Health Company Reports Record Fourth Quarter and Fiscal Year 2021 Financial Results Provides Fiscal Year 2022 Outlook Long Beach, Calif., February 22, 2022 - The Beauty Health Company ( BeautyHealth or the Company NASDAQ SKIN), a global category-creator in beauty hea
Read more →SKINThe Beauty Health Company Announces Appointment of Andrew Stanleick as President and Chief Executive Officer Highly Accomplished Brand Builder with 25+ Years of Global Beauty Retail Experience and Proven Record of Scalin
The Beauty Health Company Announces Appointment of Andrew Stanleick as President and Chief Executive Officer Highly Accomplished Brand Builder with 25+ Years of Global Beauty Retail Experience and Proven Record of Scaling Businesses Internationally Joins the BeautyHealth Team a
Read more →SKIN▼ -16.7%on this news
The Beauty Health Company Confirms Fiscal 2021 Outlook Ahead of the 2022 ICR Conference Expects Fiscal Year 2021 Net Sales Around the High End of Guidance Range and Reiterates Adjusted EBITDA Long Beach, Calif.
The Beauty Health Company Confirms Fiscal 2021 Outlook Ahead of the 2022 ICR Conference Expects Fiscal Year 2021 Net Sales Around the High End of Guidance Range and Reiterates Adjusted EBITDA Long Beach, Calif., January 10, 2022 - The Beauty Health Company ( BeautyHealth or the
Read more →SKINThe Beauty Health Company Reports Record Third Quarter 2021 Financial Results Raises Full Year 2021 Guidance Long Beach, Calif.
The Beauty Health Company Reports Record Third Quarter 2021 Financial Results Raises Full Year 2021 Guidance Long Beach, Calif., November 9, 2021 - The Beauty Health Company ( BeautyHealth or the Company NASDAQ SKIN), a global category-creator in beauty health leading the charg
Read more →SKINThe Beauty Health Company Announces the Results of the Completed Redemption of All Outstanding Public Warrants Long Beach, Calif.
The Beauty Health Company Announces the Results of the Completed Redemption of All Outstanding Public Warrants Long Beach, Calif., November 8, 2021 - The Beauty Health Company ( BeautyHealth or the Company NASDAQ SKIN), a global category-creator in beauty health leading the char
Read more →SKIN▲ +5.3%on this news
The Beauty Health Company Reminds Investors of Redemption of Public Warrants Approximately 8.47 million public warrants remain unexercised as of
The Beauty Health Company Reminds Investors of Redemption of Public Warrants Approximately 8.47 million public warrants remain unexercised as of October 18, 2021 Long Beach, Calif., October 19, 2021 - The Beauty Health Company ( BeautyHealth or the Company NASDAQ SKIN), a globa
Read more →SKINThe Beauty Health Company Announces Redemption of All Outstanding Warrants Long Beach, Calif.
The Beauty Health Company Announces Redemption of All Outstanding Warrants Long Beach, Calif., October 4, 2021 - The Beauty Health Company ( BeautyHealth or the Company NASDAQ SKIN), a global category-creator in beauty health leading the charge with its flagship brand HydraFacia
Read more →SKIN▼ -12.8%on this news
The Beauty Health Company Prices Upsized $650 Million Convertible Senior Notes Offering LONG BEACH, Calif.-(BUSINESS WIRE)
The Beauty Health Company Prices Upsized $650 Million Convertible Senior Notes Offering LONG BEACH, Calif.-(BUSINESS WIRE)-September 9, 2021-The Beauty Health Company ( BeautyHealth or the Company NASDAQ SKIN) today announced the pricing of its offering of $650,000,000 aggregate
Read more →SKINThe Beauty Health Company Announces Proposed Convertible Senior Notes Offering LONG BEACH, Calif.-(BUSINESS WIRE)
The Beauty Health Company Announces Proposed Convertible Senior Notes Offering LONG BEACH, Calif.-(BUSINESS WIRE)-Sep. 8, 2021-The Beauty Health Company ( BeautyHealth or the Company NASDAQ SKIN) today announced its intention to offer, subject to market and other conditions, $40
Read more →SKINThe Beauty Health Company Reports Record Second Quarter 2021 Financial Results Raises Full Year 2021 Sales Guidance Long Beach, Calif.
The Beauty Health Company Reports Record Second Quarter 2021 Financial Results Raises Full Year 2021 Sales Guidance Long Beach, Calif., August 10, 2021 - The Beauty Health Company ( BeautyHealth or the Company NASDAQ SKIN), a global category-creator in beauty health leading the
Read more →SKINHydraFacial and Vesper Healthcare Announce Closing of Business Combination, Combined Company Will be Known as The Beauty Health Company The Beauty Health Company will be listed on the Nasdaq Capital Market under the tick
HydraFacial and Vesper Healthcare Announce Closing of Business Combination, Combined Company Will be Known as The Beauty Health Company The Beauty Health Company will be listed on the Nasdaq Capital Market under the ticker SKIN Miami Beach, Fla. and Long Beach, Calif., May 5, 2
Read more →SKINHydraFacial Announces Record First Quarter Fiscal 2021 Preliminary Net Sales First Quarter 2021 Preliminary Financial Highlights: Q1 net sales of $47 million compared to $33 million in Q1 2020 and $35 million in Q1 2019
HydraFacial Announces Record First Quarter Fiscal 2021 Preliminary Net Sales First Quarter 2021 Preliminary Financial Highlights: Miami Beach, Florida, and Long Beach, California, April 21, 2021 The HydraFacial Company ( HydraFacial, or the Company ), an experiential category-c
Read more →SKINHydraFacial, a Beauty Health Company, Announces 2020 Preliminary Net Sales On Track to Complete Business Combination with Vesper Healthcare in the First Half of 2021 Miami Beach, Florida, and Long Beach, California
HydraFacial, a Beauty Health Company, Announces 2020 Preliminary Net Sales On Track to Complete Business Combination with Vesper Healthcare in the First Half of 2021 Miami Beach, Florida, and Long Beach, California, February 22, 2021 The HydraFacial Company ( HydraFacial, or th
Read more →SKINHydraFacial, an Experiential Beauty Health Company, and Vesper Healthcare Announce Business Combination HydraFacial is a category-creating beauty health company that provides a platform and technology to a community of p
HydraFacial, an Experiential Beauty Health Company, and Vesper Healthcare Announce Business Combination Miami Beach, Florida, and Long Beach, California, December 9, 2020 -- The HydraFacial Company ("HydraFacial," or the "Company"), a category-creating beauty health company,
Read more →SKINVESPER HEALTHCARE ACQUISITION CORP. INDEX TO FINANCIAL STATEMENT Page Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of
HEALTHCARE ACQUISITION CORP. TO FINANCIAL STATEMENT Page Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of October 2, 2020 F-3 Notes to Balance Sheet F-4 OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM the Stockholders and the Board of Dire
Read more →SKINVesper Healthcare Acquisition Corp. Announces Pricing of $400 million Initial Public Offering Brent Saunders, former Chairman and CEO of Allergan, is co-founder, CEO, President and Chairman of Vesper Healthcare
Healthcare Acquisition Corp. Announces Pricing of $400 million Initial Public Offering Saunders, former Chairman and CEO of Allergan, is co-founder, CEO, President and Chairman of Vesper Healthcare BEACH, Fla., Sept. 29, 2020 /PRNewswire/ -- Vesper Healthcare Acquisition Corp.
Read more →Competitive Position
How SKIN ranks across every disease it competes inCompetitive Position is a premium feature
See how SKIN ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial